Search

everythinglearnresearchcommunity

for

Search:↓

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

Certain immune cells, when activated by specific signals, can encourage hair growth.

Different γδ T cell types have unique roles in causing alopecia areata.

Lack of Vitamin D receptor changes skin structure and increases certain immune cells in the skin.

Some treatments for inflammatory bowel disease can cause skin problems like rashes and melanoma.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Transcranial electrical stimulation may help reduce certain immune markers in COVID-19 patients.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Belatacept may be a promising treatment for alopecia areata.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Finasteride improves immune response and reduces organ damage after trauma hemorrhage in mice.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.